158 related articles for article (PubMed ID: 9191823)
1. Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.
Gelb AB; Leavitt AD
Transfusion; 1997 Jun; 37(6):624-30. PubMed ID: 9191823
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
Wiita AP; Nambiar A
Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
[TBL] [Abstract][Full Text] [Related]
3. Cross-match-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.
Elhence P; Chaudhary RK; Nityanand S
Blood Transfus; 2014 Apr; 12(2):180-6. PubMed ID: 24333069
[TBL] [Abstract][Full Text] [Related]
4. Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients.
Friedberg RC; Donnelly SF; Mintz PD
Transfusion; 1994 Mar; 34(3):215-20. PubMed ID: 8146893
[TBL] [Abstract][Full Text] [Related]
5. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
[TBL] [Abstract][Full Text] [Related]
6. Platelet crossmatching. A direct approach to the selection of platelet transfusions for the alloimmunized thrombocytopenic patient.
Kickler TS; Ness PM; Braine HG
Am J Clin Pathol; 1988 Jul; 90(1):69-72. PubMed ID: 3389345
[TBL] [Abstract][Full Text] [Related]
7. Prospective platelet crossmatching for selection of compatible random donors.
Freedman J; Hooi C; Garvey MB
Br J Haematol; 1984 Jan; 56(1):9-18. PubMed ID: 6367808
[TBL] [Abstract][Full Text] [Related]
8. Correlation of platelet crossmatch results by Solid Phase Red Cell Adherence Assay (SPRCA) with post-transfusion platelet count increment in adult hemato-oncology patients of a tertiary care oncology centre in India.
Desai P; Sontakke P; Rajadhyaksha S; Navkudkar A
Transfus Apher Sci; 2020 Oct; 59(5):102842. PubMed ID: 32586771
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.
Heal JM; Blumberg N; Masel D
Blood; 1987 Jul; 70(1):23-30. PubMed ID: 3474041
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.
Jia Y; Li W; Liu N; Zhang K; Gong Z; Li D; Wang L; Wang D; Jing Y; Wang J; Shan X
Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of cross-match compatible platelets in multi transfused haemato-oncology patients refractory to platelet transfusion.
Chavan A; Sharma RR; Saikia B; Malhotra P; Prakash S; Hans R; Marwaha N
Transfus Apher Sci; 2019 Dec; 58(6):102657. PubMed ID: 31706911
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of platelet cross-matching in the management of patients refractory to platelet transfusions.
Salama OS; Aladl DA; El Ghannam DM; Elderiny WE
Blood Transfus; 2014 Apr; 12(2):187-94. PubMed ID: 24931840
[TBL] [Abstract][Full Text] [Related]
13. Retrospective evaluation of flow cytometry as a platelet crossmatching procedure.
Gates K; MacPherson BR
Cytometry; 1994 Sep; 18(3):123-8. PubMed ID: 7813332
[TBL] [Abstract][Full Text] [Related]
14. Platelet crossmatch testing for donor selection.
Slichter SJ
Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Human Leucocyte Antigen Mediated Platelet Transfusion Refractoriness and Platelet Crossmatching Assay in Patients with Hematologic Disorders.
Neanaey WA; Deghady AA; Nafea DA; Fahmy NM; Gouda AM
Oman Med J; 2022 Jul; 37(4):e402. PubMed ID: 35915764
[TBL] [Abstract][Full Text] [Related]
16. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity.
Petz LD; Garratty G; Calhoun L; Clark BD; Terasaki PI; Gresens C; Gornbein JA; Landaw EM; Smith R; Cecka JM
Transfusion; 2000 Dec; 40(12):1446-56. PubMed ID: 11134563
[TBL] [Abstract][Full Text] [Related]
17. A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.
Sintnicolaas K; Löwenberg B
Br J Haematol; 1996 Mar; 92(4):1005-10. PubMed ID: 8616059
[TBL] [Abstract][Full Text] [Related]
18. A cost-effectiveness evaluation of platelet crossmatching and HLA matching in the management of alloimmunized thrombocytopenic patients.
Freedman J; Gafni A; Garvey MB; Blanchette V
Transfusion; 1989; 29(3):201-7. PubMed ID: 2493693
[TBL] [Abstract][Full Text] [Related]
19. The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.
Levin MD; van der Holt B; de Veld JC; Gratama JW; de Vries W; van't Veer MB
Vox Sang; 2004 Nov; 87(4):291-8. PubMed ID: 15585026
[TBL] [Abstract][Full Text] [Related]
20. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.
Hogge DE; McConnell M; Jacobson C; Sutherland HJ; Benny WB; Massing BG
Transfusion; 1995 Aug; 35(8):645-52. PubMed ID: 7631404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
